Sungkyunkwan University (SKKU)

The 2021 flexible and printed electronics roadmap (2021) Bonnassieux Y, Brabec C, Cao Y, Carmichael TB, Chabinyc ML, Cheng KT, Cho G, et al. Journal article, Review article Neoadjuvant giredestrant (GDC-9545) + palbociclib (palbo) vs anastrozole (A) plus palbo in post-menopausal women with oestrogen receptor-positive, HER2-negative, untreated early breast cancer (ER+/HER2-eBC): Interim analysis of the randomised, open-label, phase II coopERA BC study (2021) Hurvitz SA, Park YH, Bardia A, Quiroga V, Lopez-Valverde V, Steinseifer J, Moore HM, et al. Conference contribution KEYNOTE-522 Asian subgroup: Phase III study of neoadjuvant pembrolizumab (pembro) vs placebo (pbo) plus chemotherapy (chemo) followed by adjuvant pembro vs pbo for early triple-negative breast cancer (TNBC) (2020) Dent R, Cortes J, Pusztai L, Mcarthur HL, Kuemmel S, Bergh J, Denkert C, et al. Conference contribution Hierarchical Surface Texturing of Hydroxyapatite Ceramics: Influence on the Adhesive Bonding Strength of Polymeric Polycaprolactone (2020) Biggemann J, Müller P, Köllner D, Simon S, Hoffmann P, Heik P, Lee JH, Fey T Journal article The influence of formation temperature on the solid electrolyte interphase of graphite in lithium ion batteries (2020) Yan C, Yao YX, Cai WL, Xu L, Kaskel S, Park HS, Huang JQ Journal article Pembrolizumab for early triple-negative breast cancer (2020) Schmid P, Cortes J, Pusztai L, McArthur H, Kümmel S, Bergh J, Denkert C, et al. Journal article Device Performance of Emerging Photovoltaic Materials (Version 1) (2020) Almora O, Baran D, Bazan GC, Berger C, Cabrera CI, Catchpole KR, Erten-Ela S, et al. Journal article Phase 2 study of anti-human cytomegalovirus monoclonal antibodies for prophylaxis in hematopoietic cell transplantation (2020) Maertens J, Logan AC, Jang J, Long G, Tang JL, Hwang WY, Koh LP, et al. Journal article Consensus statement for stability assessment and reporting for perovskite photovoltaics based on ISOS procedures (2020) Khenkin MV, Katz EA, Abate A, Bardizza G, Berry JJ, Brabec C, Brunetti F, et al. Journal article KEYNOTE-522: Phase III study of pembrolizumab (pembro) plus chemotherapy (chemo) vs placebo (pbo) plus chemo as neoadjuvant treatment, followed by pembro vs pbo as adjuvant treatment for early triple-negative breast cancer (TNBC) (2019) Schmid P, Cortes J, Dent R, Pusztai L, Mcarthur HL, Kuemmel S, Bergh J, et al. Conference contribution